Compare IDEXX Laboratories, Inc. (IDXX) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs State Street PDR S&P Retail ETF — how do they compare? IDEXX Laboratories, Inc. trades at $567.52 (market cap $44.95B), while State Street PDR S&P Retail ETF trades at $89.35. The key difference: State Street PDR S&P Retail ETF is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals.
| IDXX | XRT | |
|---|---|---|
Market Cap | $44.95B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $766.68 | $92.35 |
52-Week Low | $526.44 | $77.28 |
Enterprise Value | $45.85B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $566.93, down 3.36% on the day, with a neutral technical signal and strong support near $565. The company reported robust Q2 2026 earnings, beating EPS estimates with $4.27 versus $3.94 expected, and raised full-year EPS guidance to $14.69–14.94. Revenue grew 10% year-over-year, driven by companion animal diagnostics, while profitability remains high with a net margin of 25.03% in 2025. Analyst consensus is bullish with a $683.33 price target, though valuation multiples like P/E of 40.1 suggest a premium.
Outlook is positive due to consistent earnings beats, international expansion, and innovation in veterinary diagnostics, but risks include elevated valuation sensitivity, competitive pressures, and reliance on pet healthcare spending. The stock offers growth potential if execution continues, yet investors should weigh high multiples against sustained profitability trends.
XRT trades at $88.78, down 0.95% in the last session, with a bullish technical signal from moving averages and oversold RSI_6 at 28.31. The ETF focuses on retail sector exposure, with recent news highlighting resilient consumer spending trends and potential benefits from Fed easing expectations. A dividend of $0.19 is scheduled for June 2026.
Outlook remains cautiously optimistic due to technical strength and favorable retail sector dynamics, but risks include consumer sentiment volatility and inflation pressures. Analyst sentiment is mixed, with some downgrades citing macro headwinds, while institutional interest persists for diversified retail exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
